1. Catalyst Today: $NLSP signed exclusive license deal for use of data for drug development with Novartis (
$Novartis AG (NVS.US)$ ), market cap 194B, trading at $84).
2. Price target pre-news = $8. Brookline Capital updated PT to $12 today.
3. LOW float: Webull = 3.64M, Benzinga = 6M, also saw 11M on another source.
4. ZERO --- 0 SHORT SHARES available per Fintel (this is based on leading prime brokerage)
5. Current INFLOW 230M > OUTFLOW 222M